Longboat Amniotics - The Amniotic Stem Cell Company
Longboat Amniotics AB is a biopharmaceutical company created to facilitate the translation of stem cells into transformative medicines with the potential to cure serious human diseases.
- Longboat Amniotics AB recruits a new CEO in Kåre Engkilde, PhD 18 March, 2019
- Longboat Amniotics AB rekryterar ny VD i Kåre Engkilde, PhD 18 March, 2019
- Pressmeddelande (svensk version), mars 26, 2018 – Snabb utveckling i Longboat Explorers AB 26 March, 2018
- Press Release (English version), March 26, 2018 – Fast Development in Longboat Explorers AB 26 March, 2018
- Press Release – The CEO of Longboat Explorers, Anders Månsson, is invited for a panel debate on the future of Swedish Life Science 4 December, 2017